TGA-2023-0067-V367
Type II variation for application TGA-2023-0067. Type II variation: Container Closure Change for Neuravastatin — minor update
Variation Number
TGA-2023-0067-V367
Type
Type II
Application
Change
Status
Completed
Fee
€61,256
Submitted
2023-05-03
Approved
—
Description
Type II variation: Container Closure Change for Neuravastatin — minor update